International Conference on Neurology and Neurodegeneration Mechanisms

This session will explore the intricate molecular pathways involved in neurodegenerative diseases. Emphasis will be placed on understanding the biochemical processes that lead to neuronal death and dysfunction.

This track will focus on the contributions of neuroinflammation to the pathogenesis of various neurological conditions. Researchers are invited to present findings on inflammatory mediators and their impact on neuronal health.

This session will delve into the mechanisms underlying protein aggregation and its implications for neuronal integrity. Studies addressing the role of misfolded proteins in diseases such as Alzheimer's and Parkinson's will be highlighted.

This track will examine innovative neuroprotective strategies aimed at mitigating neuronal damage. Presentations will cover pharmacological and non-pharmacological interventions that show promise in neuroprotection.

This session will showcase cutting-edge research in molecular neuroscience, focusing on the latest discoveries that enhance our understanding of neuronal function and pathology. Contributions that bridge basic research and clinical applications are particularly encouraged.

This track will investigate the biological underpinnings of aging as it relates to neurodegenerative processes. Discussions will include cellular and molecular changes that occur with age and their implications for neurological health.

This session will explore the interplay between genetic predispositions and environmental influences in the development of neurological diseases. Research highlighting gene-environment interactions will be particularly relevant.

This track will focus on the application of advanced neuroimaging techniques to study neurodegenerative diseases. Presentations will cover how imaging modalities can enhance our understanding of disease progression and treatment efficacy.

This session will investigate the cellular processes that lead to neuronal death in neurodegenerative conditions. Research on apoptosis, autophagy, and necrosis will be discussed to elucidate potential therapeutic targets.

This track will bridge the gap between laboratory findings and clinical practice in neurology. Discussions will focus on how emerging research can inform diagnostic and therapeutic strategies for neurodegenerative diseases.

This session will highlight novel therapeutic approaches and drug development aimed at treating neurodegenerative disorders. Emphasis will be placed on translational research that brings laboratory discoveries to clinical application.